Q32 Bio Inc.
QTTB
$3.64
$0.236.82%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -14.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -14.66M |
| Cost of Revenue | 14.65M | 25.44M | 25.54M | 25.43M | 23.23M |
| Gross Profit | -14.65M | -25.44M | -25.54M | -25.43M | -37.89M |
| SG&A Expenses | 17.12M | 17.56M | 18.06M | 17.96M | 16.79M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.58M | 53.82M | 62.56M | 66.10M | 62.72M |
| Operating Income | -42.58M | -53.82M | -62.56M | -66.10M | -77.39M |
| Income Before Tax | -43.70M | -53.91M | -61.40M | -49.34M | -60.36M |
| Income Tax Expenses | -1.60M | -1.60M | -1.60M | -1.60M | 253.00K |
| Earnings from Continuing Operations | -42.10 | -52.30 | -59.79 | -47.73 | -60.61 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.10M | -52.30M | -59.79M | -47.73M | -60.61M |
| EBIT | -42.58M | -53.82M | -62.56M | -66.10M | -77.39M |
| EBITDA | -42.16M | -53.36M | -62.08M | -65.62M | -76.89M |
| EPS Basic | -3.45 | -4.30 | -4.95 | -3.01 | -78.22 |
| Normalized Basic EPS | -3.00 | -3.54 | -3.94 | -2.78 | -37.52 |
| EPS Diluted | -3.45 | -4.31 | -4.95 | -10.37 | -85.59 |
| Normalized Diluted EPS | -3.00 | -3.54 | -3.94 | -3.15 | -37.89 |
| Average Basic Shares Outstanding | 48.82M | 48.65M | 48.42M | 37.22M | 25.39M |
| Average Diluted Shares Outstanding | 48.82M | 48.65M | 48.42M | 38.56M | 26.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |